Immune-inflammatory response in the totally replaced hip: a review of biocompatibility aspects.
Nordström
D
D
Fourth Department of Medicine, Helsinki University Central Hospital, Finland.
Santavirta
S
S
Gristina
A
A
Konttinen
Y T
YT
D001672:Biocompatible Materials; D001843:Bone Cements / Q000009:adverse effects; D001842:Bone and Bones / Q000473:pathology; D017886:Durapatite / Q000009:adverse effects / Q000276:immunology; D005347:Fibroblasts / Q000473:pathology; D006621:Hip Joint / Q000276:immunology* / Q000473:pathology*; D006622:Hip Prosthesis / Q000009:adverse effects*; D006801:Humans; D007111:Immunity, Cellular; D007249:Inflammation / Q000209:etiology / Q000473:pathology; D008214:Lymphocytes / Q000276:immunology / Q000473:pathology; D008264:Macrophages / Q000276:immunology / Q000473:pathology; D020366:Methylmethacrylate; D008768:Methylmethacrylates / Q000009:adverse effects*; D011095:Polyethylenes / Q000009:adverse effects; D011475:Prosthesis Failure; D014025:Titanium / Q000009:adverse effects / Q000276:immunology
D001672:Biocompatible Materials; D001843:Bone Cements; D008768:Methylmethacrylates; D011095:Polyethylenes; D020366:Methylmethacrylate; D017886:Durapatite; D014025:Titanium